 Advisor Group Holdings Inc. acquired a new stake in shares of Arrowhead Pharmaceuticals Inc NASDAQ:ARWR during the first quarter, according to its most recent filing with the Securities Exchange Commission. The firm acquired 13,393 shares of the biotechnology companys stock, valued at approximately 385,000. Other hedge funds and other institutional investors have also added ... 